Search results
Results from the WOW.Com Content Network
In 2021, Demasi co-authored a paper with Robert DuBroff challenging statin therapy. [16] As of 2022, Demasi is a writer for the Brownstone Institute, an organization that has been criticized by medical experts for spreading misinformation against vaccines. [17] [18]
Aseem Malhotra is a British cardiologist, [1] health campaigner, [2] and author, who became well known during the COVID-19 pandemic after being accused of spreading misinformation about COVID-19 vaccinations. [3]
New research finds that many people currently taking statins to lower cholesterol may not actually need this medication. An analysis, published in JAMA Internal Medicine , investigates how statin ...
Sinatra was often critical of what he saw as an over-emphasis on cholesterol as an independent risk factor for heart disease and of what he considered the over-prescription of statin drugs. [21] Most statin drugs, which block an enzyme pathway necessary for the body to produce cholesterol, also block the enzyme pathway by which the body ...
Julia Kim, 64, an IT specialist from Boston, began taking a statin more than 30 years ago because of a family history of high cholesterol. But six months ago, tired of having to take the drug and ...
Cheese, like this Brie de Meaux, is high in saturated fats, and is a popular food in French cuisine.. The French paradox is an apparently paradoxical epidemiological observation that French people have a relatively low incidence of coronary heart disease (CHD), while having a diet relatively rich in saturated fats, [1] in apparent contradiction to the widely held belief that the high ...
The lipid hypothesis (also known as the cholesterol hypothesis) is a medical theory postulating a link between blood cholesterol levels and the occurrence of cardiovascular disease. A summary from 1976 described it as: "measures used to lower the plasma lipids in patients with hyperlipidemia will lead to reductions in new events of coronary ...
The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP). JUPITER was the first clinical trial to indicate that statin therapy may provide benefit to patients with low-to-normal LDL levels and no known cardiovascular disease.